Navigation Links
Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference
Date:10/29/2008

y on cancer and various women's health indications. The company expects that the first microRNA diagnostic tests applying its technology will be launched by licensed clinical laboratories in the United States in 2008.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease and the expected timing of submission for approval and launch of diagnostic tests using our microRNA technology constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover microRNA technology and to work on the application of this technology in the development of novel diagnostics and therapeutic tools, which is unproven and may never lead to marketable products or services; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its candidate tools, products and services, all of which are in early stages of development; Rosetta's ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtai
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
2. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
3. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
4. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
5. Rosetta Genomics Reports Second Quarter 2008 Financial Results
6. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
7. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
8. Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
9. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
10. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
11. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... -- Research and Markets has announced ... Report 2014" report to their offering. ... is a professional and in-depth study on the ... The report provides a basic overview of ... chain structure. The N-acetylcysteine market analysis is provided ...
(Date:9/18/2014)... -- U.S. biotech company Kultevat has strengthened its ... developed by the Donald Danforth Plant Science Center ... applications in production of natural rubber in Taraxicum ... under the direction of Roger Beachy , Ph.D., ... the Danforth Plant Science Center, and is used to ...
(Date:9/18/2014)... , Pennsylvanie, 18 septembre 2014 ... en 1974, a été depuis 40 ... les évaluations cliniques traditionnelles par des évaluations ... et sur les impacts économiques des traitements. ... A cours d,une récente ...
(Date:9/18/2014)... a group of rare diseases that afflict skeletal ... onset hits at the fetal stage and is ... gene encoding fibroblast growth factor receptor 3 (FGFR3) ... dysplasia, thanatophoric dysplasia (TD), a skeletal dysplasia that ... often lethal, and achondroplasia (ACH), which causes stunted ...
Breaking Biology Technology:Global N-acetylcysteine Industry Report 2014 2Kultevat obtains license of gene switch technology 21974 - 2014 - Mapi fĂȘte ses 40 ans 2Researchers use iPS cells to show statin effects on diseased bone 2Researchers use iPS cells to show statin effects on diseased bone 3
... Corporation , (HLC) headquartered in Milwaukee, the world's largest ... leading music education technology company, announced today that will ... music students: Essential Elements 2000 for Band Book 1 ... , ,SmartMusic is technology-based music practice system with over ...
... teachers can now better organize and plan their teaching by ... is part of their instructional process due to the release ... Additionally the new software allows all other medical disciplines to ... creates a patients instructions, the systems Visit Summary Tree lists ...
... Journal featured the news of pharmaceutical giant Pfizer ... $1.3 billion. , ,Esperion, which is based in ... useful for the treatment of the heart disease atherosclerosis. ... drugs like Lipitor for high cholesterol ($8 billion in ...
Cached Biology Technology:Logicare Improves Patient Education Systems Technology 2Holiday Gift From Big Pharma 2
(Date:9/18/2014)... 18, 2014Many Americans across racial and ethnic groups ... impact on their day-to-day life, more so than ... and speech (57% of African-Americans, 49% of non-Hispanic ... When asked which disease or ailment is the ... first among African-Americans followed by AIDS/HIV. Hispanics ...
(Date:9/18/2014)... 18, 2014 Elsevier, a world-leading provider of ... and the Australasian Research Management Society (ARMS), recognized ... at the 5th Scopus Young Researcher of the ... today at the National Convention Centre and in ... attended by guests representing Australia,s and New Zealand,s ...
(Date:9/18/2014)... lives nestling in the protective tentacles of host anemones, ... travel hundreds of kilometres across the open ocean. Although ... been predicted, this is the first time that the ... been observed. , Dr Steve Simpson, Senior Lecturer in ... Exeter, and colleagues from the Australian Research Council Centre ...
Breaking Biology News(10 mins):Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Expedition finds Nemo can travel great distances to connect populations 2Expedition finds Nemo can travel great distances to connect populations 3
... 31, 2008 - Biofuels are widely considered one of ... makers and environmentalists alike. However, unless principles and standards ... cause severe environmental impacts and reduce biodiversity the ... is currently the most widely used biofuel in the ...
... Leading academics and practitioners from the northeast United ... and nanotechnology such as the printing of human ... for relieving lower back pain at a conference ... is the first time that Brown has hosted the ...
... used by the medical profession, chloroform, has shed light on ... how such anaesthetics actually work. A discovery described ... Yahya Bahnasi, has provided a clue that may unravel the ... design new generations of anaesthetics without harmful side effects. ...
Cached Biology News:Study finds concerns with biofuels 2Brown hosts regional bioengineering conference 2Chloroform provides clue to 150 year old medical puzzle 2
Amino Acid Analysis is performed using ion-exchange separation of the amino acids from acid hydrolysates, followed by ninhydrin detection. Typical quantities required are 0.1 to 0.5 mg, depending on...
ANTI CORTIS BIN GLOB...
ANTI S. ENTERID LPS...
... ELISA Development kit contains the basic components ... to measure natural and recombinant rat L-Selectin ... Each kit contains sufficient materials to run ... that the following conditions are met: ...
Biology Products: